(Q43888085)

27 November 2017

title

The lack of association between components of metabolic syndrome and treatment resistance in depression (English)

1 reference

27 November 2017

1 reference

10

1 reference

27 November 2017

Marina Sagud

1

1 reference

27 November 2017

Alma Mihaljevic-Peles

2

1 reference

27 November 2017

Suzana Uzun

3

1 reference

27 November 2017

Bjanka Vuksan Cusa

4

1 reference

27 November 2017

Oliver Kozumplik

5

1 reference

27 November 2017

Suzan Kudlek-Mikulic

6

1 reference

27 November 2017

Maja Mustapic

7

1 reference

27 November 2017

Ivan Barisic

8

1 reference

27 November 2017

Dorotea Muck-Seler

9

1 reference

27 November 2017

publication date

12 April 2013

1 reference

27 November 2017

1 reference

27 November 2017

volume

230

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

15-21

1 reference

Serious life events among resistant and non-resistant MDD patients.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Is treatment-resistance in unipolar melancholic depression characterized by decreased serotonin₂A receptors in the dorsal prefrontal - anterior cingulate cortex?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Treatment-resistant depression and mortality after acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressive disorder: a resting-state fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Lower central serotonergic responsivity is associated with preclinical carotid artery atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Baseline lipid levels and acute treatment response to paroxetine and tianeptine in depressed women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

rTMS age-dependent response in treatment-resistant depressed subjects: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Serum cholesterol in treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Metabolic syndrome: a follow-up study of acute depressive inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Chronic, treatment-resistant depression and right fronto-striatal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Associations between anxiety, depression, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Treatment resistant depression: methodological overview and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Depression and the metabolic syndrome: gender-dependent associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3085-X

Metabolic syndrome: relevance to antidepressant treatment

21 January 2018

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Treatment-resistant depression

1 reference

12 December 2020

Depressive Symptoms and Stressful Life Events Predict Metabolic Syndrome Among Middle-Aged Women: A comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions

1 reference

12 December 2020

Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder

1 reference

12 December 2020

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

1 reference

12 December 2020

Cost burden of treatment resistance in patients with depression.

1 reference

12 December 2020

Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data

1 reference

12 December 2020

European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings

1 reference

12 December 2020

Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study.

1 reference

12 December 2020

Prevalence and management of treatment-resistant depression.

1 reference

12 December 2020

Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the "SYMFONIE" study

1 reference

12 December 2020

10.1007/S00213-013-3085-X

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1008567714

0 references

1 reference